| Eisai Pharma AG - Halaven, Injektionslösung |
| 59489 | | 01 | | Halaven | | Injektionslösung | | L01XX41 | | Eribulin | | 13.05.2011 | | |
|
| Composition |
| eribulini mesilas 1 mg corresp. eribulinum 0.88 mg, ethanolum anhydricum 0.1 ml, acidum hydrochloridum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile q.s. ad solutionem pro 2 ml. |
| Packungsbestandteile |
| Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Eribulini Mesilas | 1 mg correspond Eribulinum 0.88 mg |
| | BAG: Active Agent | Dose |
|---|
| Eribulini Mesilas | 1 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Hydrochloridum | | | Ethanol Anhydrate | 0.1 ml |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Durchstechflasche(n) | 188.66 | 221.60 | A | SL | No |
|
